摘要
Toll样受体(TLR)是一类跨膜蛋白,它在先天免疫中发挥关键作用。当TLR接触潜在威胁时会启动信号级联反应,导致细胞因子及趋化因子的释放、抗原递呈细胞的成熟和免疫活化。能激活TLR的分子可以用于疫苗开发和用作疫苗佐剂。基于由组合技术或DNA疫苗产生的抗原,疫苗佐剂可以促进更有效的疫苗的生产。这些抗原因为缺少病原体的内源先天免疫刺激性成分,通常没有免疫原性。本文完整讨论了此类未来化合物的结构性质。
关键词: 免疫佐剂,TLR,疫苗,SMIP,先天免疫,药物设计,靶向,Toll样受体。
Current Medicinal Chemistry
Title:Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists
Volume: 22 Issue: 29
Author(s): Jan Honegr, Ondrej Soukup, Rafael Dolezal, David Malinak, Marek Penhaker, Roman Prymula and Kamil Kuca
Affiliation:
关键词: 免疫佐剂,TLR,疫苗,SMIP,先天免疫,药物设计,靶向,Toll样受体。
摘要: Toll like receptors (TLRs) are a family of transmembrane proteins which play a key role in innate immunity. When TLRs come into contact with a potential threat, they initiate a signaling cascade leading to release of cytokines and chemokines, maturation of antigen presenting cells and immune activation. Molecules which can activate TLRs may be utilized for vaccine development and act as vaccine adjuvants. Adjuvants can facilitate production of more effective vaccines based on antigens produced by recombinant techniques or by DNA vaccines, which are often poorly immunogenic since they lack the endogenous innate immunostimulatory components of the pathogen. In this paper the structural properties of such prospective compounds are thoroughly discussed.
Export Options
About this article
Cite this article as:
Jan Honegr, Ondrej Soukup, Rafael Dolezal, David Malinak, Marek Penhaker, Roman Prymula and Kamil Kuca , Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists, Current Medicinal Chemistry 2015; 22 (29) . https://dx.doi.org/10.2174/0929867322666150821094634
DOI https://dx.doi.org/10.2174/0929867322666150821094634 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Control of Male Sexual Responses
Current Pharmaceutical Design Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD
Current Medicinal Chemistry Age Matching Animal Models to Humans - Theoretical Considerations
Current Drug Discovery Technologies Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Current Pharmacogenomics Metabolic Adaptations to Pregnancy in Healthy and Gestational Diabetic Pregnancies: The Pancreas - Placenta Axis
Current Vascular Pharmacology The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer
Current Medicinal Chemistry Cyclooxygenase Inhibitory Natural Products: Current Status
Current Medicinal Chemistry A Short Review on Important Drugs Under Clinical Trial Against COVID-19
Mini-Reviews in Medicinal Chemistry COX-Inhibiting Nitric Oxide Donors (CINODs): Potential Benefits on Cardiovascular and Renal Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Preface
Current Pharmaceutical Biotechnology Chemical Modifications of Ketoprofen (NSAID) in Search of Better Lead Compounds: A Review of Literature From 2004-2016
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-Infective and Anti-Tumor Agents Based on the Depletion of Immune Suppressive Effects
Current Medicinal Chemistry The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells
Current Pharmaceutical Design Retracted: Tocotrienols and its Role in Cardiovascular Health- a Lead for Drug Design
Current Pharmaceutical Design Editorial [Innovative Therapeutic Approaches for the Treatment of Pediatric Autoimmune and Inflammatory Diseases Executive (Guest Editor: Giorgio Zauli)]
Current Pharmaceutical Design Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design Microencapsulation for Human Islet Transplantation
Micro and Nanosystems